Kuruluşlararası Daimî Komite (IASC) Acil Durumlarda Ruh Sağlığı ve Psikososyal Destek Referans Grubu
This thematic brief accompanies the Working for Health 2022–2030 Action Plan, providing a rationale for the related actions of the Working for Health progression model (see Annex). This brief aims to inform Member States, non-state actors and other stakeholders vested in implementing the Action ...Plan to consider the context of planning and financing for the health and care workforce, including the relevant policy landscape, key challenges and future directions.
In doing so, it provides an expanded exploration of the themes beyond what is provided in the Action Plan Itself, and reflects the topical issues and considerations that shaped its design, including those issues identified in the World Health Assembly Resolution WHA74.14 to protect, safeguard and invest in the health and care workforce. The importance of these themes was again emphasized at the Seventy-fifth WHA, when Resolution WHA75.17: Human resources for health, was co-sponsored by over 100 Member States, calling for the adoption and implementation of the Working for Health 2022–2030 Action Plan and utilization of the related Global Health and Care Worker Compact.
more
Die Würde des Menschen ist unantastbar – wird dieses Gebot auch bei der gesundheitlichen Versorgung von Geflüchteten eingehalten? Die gesundheitliche Versorgung von Asylsuchenden in Deutschland ist geregelt durch das bundesdeutsche Asylbewerberleistungsgesetz (AsylbLG). Die Bundesregierung sieht... allein die Länder in der Verantwortung für die Umsetzung des AsylbLG. Dabei kommt sie bei der Frage der Gesundheitsversorgung von Asylsuchenden jedoch ihren eigenen Hausaufgaben nicht nach: Seit 2015 ist in Deutschland zwingend die EU-Aufnahmerichtlinie von 2013 umzusetzen. Jedoch sind im AsylbLG weder die Leistungsansprüche besonders schutzbedürftiger Asylsuchender nach Definition der EU-Aufnahmerichtlinie geregelt, noch gibt es Hinweise zum Umgang mit erkrankten besonders schutzbedürftigen Asylsuchenden, die leistungsrechtlichen Sanktionen unterliegen. Das Policy Paper gibt einen Überblick über die rechtlichen Rahmenbedingungen auf nationaler und supranationaler Ebene und leitet unter Einbeziehung von wissenschaftlichen Forschungsbefunden Handlungsempfehlungen ab.
more
(für Asylsuchende, Geflüchtete und Anerkannte). Handreichung zum Infektionsschutz in Einrichtungen zur gemein-schaftlichen Unterbringung (EgU) von Asylbewerbern
Stand März 2022
Introduction
Chapitre A.4
Edition en français Traduction : Eleanor O’Boyle
Sous la direction de : Priscille Gérardin
Avec le soutien de la SFPEADA
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...volved in vaccine research, financing, regulation and policy-making, manufacturing, introduction and procurement. The goal is to accelerate development of effective vaccines against TB and their rapid introduction into countries.
more
Morbidity and Mortality Weekly Report (MMWR) January 16, 2015 / 64(01);20-27
Blueprint for EECA countries, first edition
МОДЕЛЬ ПРОТИВОТУБЕРКУЛЕЗНОЙ ПОМОЩИ, ОРИЕНТИРОВАННАЯ НА НУЖДЫ ЛЮДЕЙ
Концептуальный проект модели для стран Восточной Европы и Центрально...й Азии, первое издание
more
Saving Lives: Universal access to Trauma Services in Kenya
This report documents the secondary humanitarian problems and impacts of large-scale Ebola outbreak on the different humanitarian sectors, to provide a non-exhaustive plan to help future responders. A large scale Ebola outbreak, in this document, refers to an epidemic with an unprecedented scale, ge...ographical spread and duration.
more
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...t of diphtheria. There is a worldwide shortage of DAT and evidence based recommendations on the use of DAT were requested by many Member States.
The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.
This clinical practice guideline has been rapidly developed recognizing the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria. Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving.
more
Throughout the gestational period, it is important for obstetric health care facilities to strengthen health counselling, screening, and follow-ups for pregnant women, while incorporating screening, hand hygiene practice, good respiratory etiquette and infection prevention control precautions. These... screening procedures will help determine individualised precautions necessary, such as the wearing of face masks during consultations.
more
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a...nd middle-income countries. The report discusses strategies for preventing Type 2 diabetes, managing diabetes effectively, and reducing complications through integrated healthcare approaches. It emphasizes the need for global action, national policies, and collaboration across sectors to address diabetes and improve health outcomes worldwide.
more
Conflict and Health 2015, 9:8 doi:10.1186/s13031-015-0035-8